Sentence examples for l multiple from inspiring English sources

The proof of Proposition 4 will be complete if we show that each term in the right-hand side of the above inequality is bounded by a constant (independent of l) multiple of n −δ.

Σ f i f i ∗ T f i ( e j ) ≤ C ( e j ) ∀ e j ∈ E. The distribution of a flow f i on l multiple paths requires that the aggregate of the sub-flows must not exceed the demand of the flow itself.

Several Leishmania species are able to cause a wide spectrum of clinical manifestations of cutaneous leishmaniasis, ranging from the mild cutaneous form (localized cutaneous leishmaniasis; LCL), multiple non-ulcerative nodules (diffuse cutaneous leishmaniasis; DCL) and the disfiguring mucosal form (mucocutaneous leishmaniasis; MCL).

Donor line carries a source of Flp recombinase and phiC31 integrase, and the core cassette for a specific phase (0, 1, or 2) encoding a (GGS 4 flexible linker (L), multiple tags EGFP-FlAsH-StrepII-TEVcs-3xFlag (GFSTF), another (GGS 4 flexible linker, and a splice donor (SD), which is flanked by two inverted attB and two FRT sites oriented in that same direction.

Data of Merino sheep descended from two divergent selection lines for (H line) and against (L line) multiple rearing ability were collected in three different trials to compare response to stressful situations between lines.

By means of the open-loop UL TPC from Eq. (1), it is possible to upper limit DR since differences in the total signal loss L between multiple UEs can be compensated by setting α>0.

In this study, a 36 m long/0.3 L volume multiple pass absorption gas cell was used to achieve a 0.1-s flow resolution for the mainstream smoke and 0.4 s for the sidestream smoke.

(G ) Overlay of SEC-MALS chromatograms of SAS-5CC-L at multiple concentrations, showing scaled light scattering intensity vs elution volume.

Our previous reports of significantly different clinical outcome of L-L compared to multiple metastatic disease [ 3], particularly in KRAS wild-type patients, while not in KRAS mutant [ 5], were confirmed in young-elderly patients and should be prospectively verified.

Pathologic CRs were obtained in 2 KRAS mutant patients, harboring c.35 G>T and c.35 G>A mutations, with multiple L-L metastases and single liver plus single lung metastases, respectively, who obtained a clinical partial response after treatment.

For I = I fin, ℐ-asymptotically lacunary statistical equivalent of multiple L coincides with asymptotically lacunary statistical equivalent of multiple L, which is defined in [3].